Skip to main content
Top
Published in: Supportive Care in Cancer 7/2018

01-07-2018 | Original Article

Financial and socio-economic factors influencing pre- and post-cancer therapy oral care

Authors: Derek K. Smith, Emily H. Castellanos, Barbara A. Murphy

Published in: Supportive Care in Cancer | Issue 7/2018

Login to get access

Abstract

Purpose

The primary objective of this study is to evaluate how attendance at dental visits may change as cancer patients move through pre-diagnosis, diagnosis, and into survivorship.

Methods

The Health and Retirement Study consists of longitudinal survey data collected biannually detailing financial and health information in subjects over 51 years old. We assessed a subset of 4195 patients who received a new cancer diagnosis during the study period. The odds of reporting a dental visit were examined using a mixed effects logistic regression model. A propensity score weighted analysis of the association between dental attendance and survival was also undertaken.

Results

The odds of attending a dental visit were substantially lower in the peri-diagnosis period OR = 0.784 (0.700, 0.876) and the post-diagnosis period OR = 0.734 (0.655, 0.823) compared to pre-diagnosis. This effect persisted in patients who survived for at least 2 years indicating that the decline in oral health visits was not due to low expected survival. After propensity score weighting, patients who attended a dental visit in the peri-diagnosis period demonstrated a reduced hazard of all-cause mortality HR = 0.825 (0.681, 0.979) compared with those with no attendance.

Conclusions

Dental attendance decreases by a statistically and clinically significant amount both during and after cancer therapy despite guideline recommendations encouraging dental referral and monitoring for many types of cancer therapy. Attendance at dental appointments during cancer therapy is associated with improved survival, which is likely due to a combination of direct and indirect effects.
Literature
1.
go back to reference Dodd MJ et al (2001) A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage 21(6):498–505CrossRefPubMed Dodd MJ et al (2001) A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage 21(6):498–505CrossRefPubMed
2.
go back to reference Epstein JB et al (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23(5):389–398CrossRefPubMed Epstein JB et al (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23(5):389–398CrossRefPubMed
3.
go back to reference Epstein JB et al (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30(11):785–792CrossRefPubMed Epstein JB et al (2002) Quality of life, taste, olfactory and oral function following high-dose chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 30(11):785–792CrossRefPubMed
4.
go back to reference Chambers MS et al (2004) Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 26(9):796–807CrossRefPubMed Chambers MS et al (2004) Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 26(9):796–807CrossRefPubMed
5.
go back to reference Dirix P et al (2008) The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer 16(2):171–179CrossRefPubMed Dirix P et al (2008) The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer 16(2):171–179CrossRefPubMed
6.
go back to reference Kartin PT et al (2014) Effect of an oral mucositis protocol on quality of life of patients with head and neck cancer treated with radiation therapy. Clin J Oncol Nurs 18(6):E118–E125CrossRefPubMed Kartin PT et al (2014) Effect of an oral mucositis protocol on quality of life of patients with head and neck cancer treated with radiation therapy. Clin J Oncol Nurs 18(6):E118–E125CrossRefPubMed
7.
go back to reference Epstein JB et al (2010) A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer 18(8):1023–1031CrossRefPubMed Epstein JB et al (2010) A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer 18(8):1023–1031CrossRefPubMed
8.
go back to reference Jensen SB et al (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18(8):1039–1060CrossRefPubMed Jensen SB et al (2010) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18(8):1039–1060CrossRefPubMed
9.
go back to reference Epstein JB et al (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422CrossRefPubMed Epstein JB et al (2012) Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 62(6):400–422CrossRefPubMed
10.
go back to reference Smith, J., et al. (2016) Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia. Support Care Cancer Smith, J., et al. (2016) Nutritional issues and body weight in long-term survivors of allogeneic blood and marrow transplant (BMT) in NSW Australia. Support Care Cancer
11.
go back to reference Chambers MS et al (1995) Oral and dental management of the cancer patient: prevention and treatment of complications. Support Care Cancer 3(3):168–175CrossRefPubMed Chambers MS et al (1995) Oral and dental management of the cancer patient: prevention and treatment of complications. Support Care Cancer 3(3):168–175CrossRefPubMed
12.
go back to reference Koga DH, Salvajoli JV, Alves FA (2008) Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis 14(1):40–44CrossRefPubMed Koga DH, Salvajoli JV, Alves FA (2008) Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis 14(1):40–44CrossRefPubMed
14.
go back to reference Hancock PJ, Epstein JB, Sadler GR (2003) Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc 69(9):585–590PubMed Hancock PJ, Epstein JB, Sadler GR (2003) Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc 69(9):585–590PubMed
15.
go back to reference NIH Publication No. 09-4360, Oral complications of cancer treatment: what the oncology team can do NIH Publication No. 09-4360, Oral complications of cancer treatment: what the oncology team can do
16.
go back to reference Kumar N et al (2013) The oral management of oncology patients requiring radiotherapy, chemotherapy and/or bone marrow transplantation. Faculty Dental Journal 4(4):200–203CrossRef Kumar N et al (2013) The oral management of oncology patients requiring radiotherapy, chemotherapy and/or bone marrow transplantation. Faculty Dental Journal 4(4):200–203CrossRef
17.
go back to reference Health and Retirement Study, Rand HRS public use dataset. 2016, University of Michigan with funding from the National Institute on Aging (grant number NIA U01AG009740): Ann Arbor, MI Health and Retirement Study, Rand HRS public use dataset. 2016, University of Michigan with funding from the National Institute on Aging (grant number NIA U01AG009740): Ann Arbor, MI
18.
go back to reference Li L, Greene T (2013) A weighting analogue to pair matching in propensity score analysis. Int J Biostat 9(2):215–234CrossRefPubMed Li L, Greene T (2013) A weighting analogue to pair matching in propensity score analysis. Int J Biostat 9(2):215–234CrossRefPubMed
19.
go back to reference Pan W (2000) A multiple imputation approach to Cox regression with interval-censored data. Biometrics 56(1):199–203CrossRefPubMed Pan W (2000) A multiple imputation approach to Cox regression with interval-censored data. Biometrics 56(1):199–203CrossRefPubMed
Metadata
Title
Financial and socio-economic factors influencing pre- and post-cancer therapy oral care
Authors
Derek K. Smith
Emily H. Castellanos
Barbara A. Murphy
Publication date
01-07-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-4033-9

Other articles of this Issue 7/2018

Supportive Care in Cancer 7/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine